These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

404 related articles for article (PubMed ID: 30034830)

  • 1. Latest development of liquid biopsy.
    Cheung AH; Chow C; To KF
    J Thorac Dis; 2018 Jun; 10(Suppl 14):S1645-S1651. PubMed ID: 30034830
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Liquid Biopsy: General Concepts.
    Poulet G; Massias J; Taly V
    Acta Cytol; 2019; 63(6):449-455. PubMed ID: 31091522
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current and future applications of liquid biopsy in non-small-cell lung cancer-a narrative review.
    Tomasik B; Skrzypski M; Bieńkowski M; Dziadziuszko R; Jassem J
    Transl Lung Cancer Res; 2023 Mar; 12(3):594-614. PubMed ID: 37057121
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical Utility and Application of Liquid Biopsy Genotyping in Lung Cancer: A Comprehensive Review.
    Nigro MC; Marchese PV; Deiana C; Casadio C; Galvani L; Di Federico A; De Giglio A
    Lung Cancer (Auckl); 2023; 14():11-25. PubMed ID: 36762267
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circulating cell-free nucleic acids and platelets as a liquid biopsy in the provision of personalized therapy for lung cancer patients.
    Sorber L; Zwaenepoel K; Deschoolmeester V; Van Schil PE; Van Meerbeeck J; Lardon F; Rolfo C; Pauwels P
    Lung Cancer; 2017 May; 107():100-107. PubMed ID: 27180141
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Liquid biopsy and PCR-free ultrasensitive detection systems in oncology (Review).
    Finotti A; Allegretti M; Gasparello J; Giacomini P; Spandidos DA; Spoto G; Gambari R
    Int J Oncol; 2018 Oct; 53(4):1395-1434. PubMed ID: 30085333
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Liquid biopsy: a step forward towards precision medicine in urologic malignancies.
    Di Meo A; Bartlett J; Cheng Y; Pasic MD; Yousef GM
    Mol Cancer; 2017 Apr; 16(1):80. PubMed ID: 28410618
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical Utility of Liquid Diagnostic Platforms in Non-Small Cell Lung Cancer.
    Levy B; Hu ZI; Cordova KN; Close S; Lee K; Becker D
    Oncologist; 2016 Sep; 21(9):1121-30. PubMed ID: 27388233
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circulating tumor DNA and liquid biopsy: opportunities, challenges, and recent advances in detection technologies.
    Gorgannezhad L; Umer M; Islam MN; Nguyen NT; Shiddiky MJA
    Lab Chip; 2018 Apr; 18(8):1174-1196. PubMed ID: 29569666
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circulating tumor DNA - Current state of play and future perspectives.
    De Rubis G; Krishnan SR; Bebawy M
    Pharmacol Res; 2018 Oct; 136():35-44. PubMed ID: 30142423
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Liquid biopsy: state of reproductive medicine and beyond.
    Schobers G; Koeck R; Pellaers D; Stevens SJC; Macville MVE; Paulussen ADC; Coonen E; van den Wijngaard A; de Die-Smulders C; de Wert G; Brunner HG; Zamani Esteki M
    Hum Reprod; 2021 Oct; 36(11):2824-2839. PubMed ID: 34562078
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Liquid biopsy based biomarkers in non-small cell lung cancer for diagnosis and treatment monitoring.
    Pérez-Callejo D; Romero A; Provencio M; Torrente M
    Transl Lung Cancer Res; 2016 Oct; 5(5):455-465. PubMed ID: 27826527
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current and Future Perspectives of Cell-Free DNA in Liquid Biopsy.
    Liu S; Wang J
    Curr Issues Mol Biol; 2022 Jun; 44(6):2695-2709. PubMed ID: 35735625
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Liquid biopsy for human cancer: cancer screening, monitoring, and treatment.
    Wang H; Zhang Y; Zhang H; Cao H; Mao J; Chen X; Wang L; Zhang N; Luo P; Xue J; Qi X; Dong X; Liu G; Cheng Q
    MedComm (2020); 2024 Jun; 5(6):e564. PubMed ID: 38807975
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Advances in early detection methods for solid tumors.
    Jiang B; Xie D; Wang S; Li X; Wu G
    Front Genet; 2023; 14():1091223. PubMed ID: 36911396
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Liquid Biopsy beyond Circulating Tumor Cells and Cell-Free DNA.
    Junqueira-Neto S; Batista IA; Costa JL; Melo SA
    Acta Cytol; 2019; 63(6):479-488. PubMed ID: 30783027
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Liquid Biopsy for Lung Cancer: State of the Art, Limitations and Future Developments.
    Di Capua D; Bracken-Clarke D; Ronan K; Baird AM; Finn S
    Cancers (Basel); 2021 Aug; 13(16):. PubMed ID: 34439082
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Liquid biopsy in ovarian cancer: recent advances in circulating extracellular vesicle detection for early diagnosis and monitoring progression.
    Chang L; Ni J; Zhu Y; Pang B; Graham P; Zhang H; Li Y
    Theranostics; 2019; 9(14):4130-4140. PubMed ID: 31281536
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Future perspectives of circulating tumor DNA in colorectal cancer.
    Nadal C; Winder T; Gerger A; Tougeron D
    Tumour Biol; 2017 May; 39(5):1010428317705749. PubMed ID: 28488528
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical Applications of Liquid Biopsy in Gastric Cancer.
    Chivu-Economescu M; Necula L; Matei L; Dragu D; Bleotu C; Diaconu CC
    Front Med (Lausanne); 2021; 8():749250. PubMed ID: 34651002
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.